All In Biotech

Drug Trial Radar · NCT07801495

A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase 2a/b Study Assessing the Efficacy, Safety and Tolerability of DDY391 in Participants With Active Moderate to Severe Psoriatic Arthritis

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 220 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

220

Planned (sponsor's estimate)

Start

Oct 19, 2026

Primary completion

Dec 13, 2028

Study completion Jan 12, 2029

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Sep 3, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this Phase 2a/b study is: 1. to evaluate the efficacy, safety and tolerability of DDY391 in participants with psoriatic arthritis (PsA). 2. to determine the dose-response relationship of DDY391 in participants with PsA to support dose selection for Phase 3.

Conditions

  • Moderate to Severe Psoriatic Arthritis

Interventions

  • DDY391Drug

    DDY391

  • PlaceboDrug

    Matching placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A: Number of participants achieving American College of Rheumatology 50 (ACR50) responseTime frame: Week 12
  2. Part A and B: Number of participants achieving American College of Rheumatology 50 (ACR50) responseTime frame: Week 12

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Newport Huntington Medical Group

    Huntington Beach, California · Recruiting

  • Altoona Center for Clin Res

    Duncansville, Pennsylvania · Recruiting

  • WCG CR Philadelphia LLC

    Philadelphia, Pennsylvania · Recruiting

  • Shelby Research LLC

    Memphis, Tennessee · Recruiting

  • Precision Comprehensive Research

    Colleyville, Texas · Recruiting

  • Arthritis Care of Texas

    Corpus Christi, Texas · Recruiting

  • Biopharma Informatic LLC

    Katy, Texas · Recruiting

  • Rheumatology Associates of South Texas

    San Antonio, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.